Cancer,bcr_patient_barcode,drug_name,DrugBank ID,measure_of_response,days_to_drug_therapy_start,days_to_drug_therapy_end,days_to_initial_pathologic_diagnosis,method_of_sample_procurement,days_to_sample_procurement,days_to_new_tumor_event_after_initial_treatment,additional_pharmaceutical_therapy,new_tumor_event_additional_surgery_procedure,history_of_neoadjuvant_treatment,Classification,file_id,file_name,SMILES,uniqueID
Bladder Urothelial Carcinoma (BLCA),TCGA-DK-AA76,Cisplatin,DB00515,Complete Response,54,114,0,Transurethral resection (TURBT),0,,,,No,1,3f8e9328-2b3d-4f66-a5ee-77690a590d5f,9bd9ca6e-43fa-404b-b342-82f63e6f31a9.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-DK-AA76,Gemcitabine,DB00441,Complete Response,54,114,0,Transurethral resection (TURBT),0,,,,No,1,3f8e9328-2b3d-4f66-a5ee-77690a590d5f,9bd9ca6e-43fa-404b-b342-82f63e6f31a9.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3C,Cisplatin,DB00515,Clinical Progressive Disease,111,200,0,Transurethral resection (TURBT),0,,,,No,0,1abd183c-a740-42d6-b913-7c41a794a3a8,109dbe32-3037-4242-aef6-946f5d792b4f.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3C,Gemcitabine,DB00441,Clinical Progressive Disease,111,200,0,Transurethral resection (TURBT),0,,,,No,0,1abd183c-a740-42d6-b913-7c41a794a3a8,109dbe32-3037-4242-aef6-946f5d792b4f.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3D,Erlotinib,DB00530,Partial Response,-5,15,0,Transurethral resection (TURBT),-20,,,,No,1,860b5719-8396-47cb-b70a-016f121240fe,f676396e-4927-4e80-802c-c47b5d453ca5.rna_seq.augmented_star_gene_counts.tsv,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,7
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3D,Methotrexate,DB00563,Stable Disease,115,158,0,Transurethral resection (TURBT),-20,,,,No,0,860b5719-8396-47cb-b70a-016f121240fe,f676396e-4927-4e80-802c-c47b5d453ca5.rna_seq.augmented_star_gene_counts.tsv,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,6
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3D,Doxorubicin,DB00997,Stable Disease,115,158,0,Transurethral resection (TURBT),-20,,,,No,0,860b5719-8396-47cb-b70a-016f121240fe,f676396e-4927-4e80-802c-c47b5d453ca5.rna_seq.augmented_star_gene_counts.tsv,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,9
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3D,Vinblastine,DB00570,Stable Disease,115,158,0,Transurethral resection (TURBT),-20,,,,No,0,860b5719-8396-47cb-b70a-016f121240fe,f676396e-4927-4e80-802c-c47b5d453ca5.rna_seq.augmented_star_gene_counts.tsv,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,5
Bladder Urothelial Carcinoma (BLCA),TCGA-G2-AA3D,Cisplatin,DB00515,Stable Disease,115,158,0,Transurethral resection (TURBT),-20,,,,No,0,860b5719-8396-47cb-b70a-016f121240fe,f676396e-4927-4e80-802c-c47b5d453ca5.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAME,Carboplatin,DB00958,Clinical Progressive Disease,2569,2569,0,Cystectomy,22,1651,NO,YES,No,0,6d492b0e-8e87-43d7-b9cb-7a57eca9494f,5dc073f5-60f5-40a6-ae0a-4853f9a398c4.rna_seq.augmented_star_gene_counts.tsv,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],1
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAME,Gemcitabine,DB00441,Partial Response,2500,2543,0,Cystectomy,22,1651,NO,YES,No,1,6d492b0e-8e87-43d7-b9cb-7a57eca9494f,5dc073f5-60f5-40a6-ae0a-4853f9a398c4.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAME,Cisplatin,DB00515,Partial Response,2500,2543,0,Cystectomy,22,1651,NO,YES,No,1,6d492b0e-8e87-43d7-b9cb-7a57eca9494f,5dc073f5-60f5-40a6-ae0a-4853f9a398c4.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMJ,Gemcitabine,DB00441,Complete Response,82,143,0,Cystectomy,29,,,,No,1,ff95132b-c85d-42e1-bd4f-70a1e1171d80,ee15f8f7-b15b-4f47-8a1b-6273f4c4a188.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMJ,Platinum,,Complete Response,82,143,0,Cystectomy,29,,,,No,1,ff95132b-c85d-42e1-bd4f-70a1e1171d80,ee15f8f7-b15b-4f47-8a1b-6273f4c4a188.rna_seq.augmented_star_gene_counts.tsv,[Pt],11
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMR,Cisplatin,DB00515,Complete Response,119,192,0,Cystectomy,21,,,,No,1,4d99171a-0545-4eb4-b99a-ee0d4db75920,5ee1b32a-49cb-416e-8cf8-b3d9f05489a3.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMR,Gemcitabine,DB00441,Complete Response,119,192,0,Cystectomy,21,,,,No,1,4d99171a-0545-4eb4-b99a-ee0d4db75920,5ee1b32a-49cb-416e-8cf8-b3d9f05489a3.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMY,Gemcitabine,DB00441,Complete Response,669,853,0,Cystectomy,219,637,YES,NO,No,1,9b7ee08d-b03c-4c4e-a295-d27cdeff5e92,e1f9317d-2b63-4b38-b1ae-591a21d64428.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMY,Carboplatin,DB00958,Complete Response,671,853,0,Cystectomy,219,637,YES,NO,No,1,9b7ee08d-b03c-4c4e-a295-d27cdeff5e92,e1f9317d-2b63-4b38-b1ae-591a21d64428.rna_seq.augmented_star_gene_counts.tsv,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],1
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAMZ,BCG,,Clinical Progressive Disease,0,0,0,Cystectomy,50,1344,NO,NO,No,0,4d356fe2-d8c0-4e7a-bc54-98887c7d0847,4ecaeb4e-2ca9-48d2-b2ca-95e6a2edd050.rna_seq.augmented_star_gene_counts.tsv,CC1=C(C(=C(C=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=CC(=C(C(=C4C)Br)O)Br)Br)O)Br,3
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN0,E7389,DB04940,Partial Response,614,866,0,Cystectomy,47,603,YES,YES,No,1,ac728bb8-2b0c-4a0a-9c80-23e0fb768393,7fd86c81-d69b-4e3e-b60f-f4d53eb5e2a5.rna_seq.augmented_star_gene_counts.tsv,C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O.CS(=O)(=O)O,8
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN0,Ifosfamide,DB01181,Partial Response,898,1052,0,Cystectomy,47,603,YES,YES,No,1,ac728bb8-2b0c-4a0a-9c80-23e0fb768393,7fd86c81-d69b-4e3e-b60f-f4d53eb5e2a5.rna_seq.augmented_star_gene_counts.tsv,C1CN(P(=O)(OC1)NCCCl)CCCl,2
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN0,Cisplatin,DB00515,Partial Response,898,1052,0,Cystectomy,47,603,YES,YES,No,1,ac728bb8-2b0c-4a0a-9c80-23e0fb768393,7fd86c81-d69b-4e3e-b60f-f4d53eb5e2a5.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN3,Cisplatin,DB00515,Complete Response,121,142,0,Cystectomy,32,,,,No,1,1b490f2b-97bb-4229-853d-d566ecc341d6,3f7a9b50-276a-40fd-94fa-390a6f174e10.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN3,Gemcitabine,DB00441,Complete Response,121,142,0,Cystectomy,32,,,,No,1,1b490f2b-97bb-4229-853d-d566ecc341d6,3f7a9b50-276a-40fd-94fa-390a6f174e10.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN5,Cisplatin,DB00515,Complete Response,127,211,0,Cystectomy,31,,,,No,1,99d9ed5a-e689-47cb-abb2-0c6a69772fe2,4b27400f-f5ab-4f18-a2e1-f45b03a31f13.rna_seq.augmented_star_gene_counts.tsv,N.N.Cl[Pt]Cl,10
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN5,Gemcitabine,DB00441,Complete Response,127,211,0,Cystectomy,31,,,,No,1,99d9ed5a-e689-47cb-abb2-0c6a69772fe2,4b27400f-f5ab-4f18-a2e1-f45b03a31f13.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN7,Gemcitabine,DB00441,Partial Response,162,200,0,Cystectomy,44,321,YES,NO,No,1,3bc655bf-2b44-4d75-b1d6-47c12e1af743,f0e88c42-951e-4386-8a40-565e22938f57.rna_seq.augmented_star_gene_counts.tsv,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,0
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN7,Ifosfamide,DB01181,Clinical Progressive Disease,351,374,0,Cystectomy,44,321,YES,NO,No,0,3bc655bf-2b44-4d75-b1d6-47c12e1af743,f0e88c42-951e-4386-8a40-565e22938f57.rna_seq.augmented_star_gene_counts.tsv,C1CN(P(=O)(OC1)NCCCl)CCCl,2
Bladder Urothelial Carcinoma (BLCA),TCGA-XF-AAN7,Paclitaxel,DB01229,Stable Disease,0,9,0,Cystectomy,44,321,YES,NO,No,0,3bc655bf-2b44-4d75-b1d6-47c12e1af743,f0e88c42-951e-4386-8a40-565e22938f57.rna_seq.augmented_star_gene_counts.tsv,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,4
